Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OUTCOV: Early Outpatient Treatment for COVID-19
NCT04365582Phase 3Withdrawn
- Sponsor
- Fondation Hôpital Saint-Joseph
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of azithromycin, hydroxychloroquine, lopinavir, ritonavir in coronavirus disease 2019 (COVID-19), sponsored by Fondation Hôpital Saint-Joseph. Planned start May 2020; status: withdrawn.
02
Drugs
azithromycinhydroxychloroquinelopinavirritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04365582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04365582.